id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
aiua-5924	Perletti, Gianpaolo	Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer	2016	2	.pdf	application/pdf	1061	43	48	Perletti and co-authors’ response (Row 5): Unclear risk of bias does not represent a negative evaluation of the quality of the evidence. The figures are too small to allow evaluation of the reasons for such (likely accidental) out-selection of patients with baseline visceral disease in the Cabazitaxel arm.	cache/aiua-5924.pdf	txt/aiua-5924.txt